Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Novel, orally bioavailable anticoagulants discovered at Lilly

Feb. 16, 1999

Abciximab undergoing clinical evaluation in acute ischemic stroke

Feb. 9, 1999

Clot-dissolving drug significantly improves disability outcome in phase III stroke trial

Feb. 9, 1999

Roberts and Yuhan enter distribution agreement for Agrylin in Korea

Feb. 3, 1999

Otsuka discovers new platelet aggregation inhibitors and antithrombotic agents

Feb. 1, 1999

U.K. launch announced for hemophilia B treatment

Jan. 29, 1999

Searle drops development of gpIIb/IIIa receptor antagonists

Jan. 25, 1999

Potent heterocyclic antithrombotic agents discovered by Lilly

Jan. 25, 1999

Integrin receptor antagonists, prodrugs and transdermal iontophoretic administration

Jan. 22, 1999

DuPont presents potent, orally active antiplatelet agent with good duration of action

Jan. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...